ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,256.21
1.75%
S&P 500
5,068.96
1.01%
Dow Jones
38,254.17
0.93%
US Dollar vs Yen
153.1915
-1.62%
Brent Oil
83.73
0.23%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) ニュース

VIR Vir Biotechnology Inc

9.095
0.355 (4.06%)
最終更新日： 03:52:11
15分遅延
名称 銘柄コード 市場 種別
Vir Biotechnology Inc VIR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.355 4.06% 9.095 03:52:11
始値 安値 高値 終値 前日終値
8.91 8.745 9.155 8.74
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0105:05BWVir Biotechnology to Participate in the BofA Securities..
2024/4/1821:00BWVir Biotechnology Announces Nomination of Norbert..
2024/4/1205:30BWVir Biotechnology to Provide Business Update and Report..
2024/3/0522:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
2024/2/2709:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2709:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2709:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2709:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2706:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2322:05BWVir Biotechnology to Participate in Upcoming Investor..
2024/2/2306:12EDGAR2Form 8-K - Current report
2024/2/2306:05BWVir Biotechnology Provides Corporate Update and Reports..
2024/2/2106:33EDGAR2Form 8-K - Current report
2024/2/2106:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
2024/2/1708:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0206:05BWVir Biotechnology to Provide Business Update and Report..
2024/1/0404:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1419:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
2023/12/1406:06EDGAR2Form 8-K - Current report
2023/12/1406:05BWVir Biotechnology Announces Strategic Steps to Reduce..
2023/12/0706:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
2023/11/1322:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
2023/11/1022:00BWVir Biotechnology to Present Late-Breaking Data from Its..
2023/11/0822:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
2023/11/0405:37EDGAR2Form 8-K - Current report
2023/11/0405:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/0405:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:09EDGAR2Form 8-K - Current report
2023/11/0305:05BWVir Biotechnology Provides Corporate Update and Reports..
2023/10/3021:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
2023/10/1305:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
2023/10/1121:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
2023/10/0605:30GLOBEVir Biotechnology to Provide Business Update and Report..
2023/10/0321:01EDGAR2Form 8-K - Current report
2023/10/0320:59GLOBEVir Biotechnology Awarded BARDA Funding to Support..
2023/9/2021:00GLOBEVir Biotechnology Announces First Participant Dosed in New..
2023/9/2019:02EDGAR2Form 8-K - Current report
2023/8/3005:30GLOBEVir Biotechnology to Participate in Upcoming Investor..
2023/8/0505:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:14EDGAR2Form 8-K - Current report
2023/8/0405:05GLOBEVir Biotechnology Provides Corporate Update and Reports..
2023/7/2705:05GLOBEVir Biotechnology to Provide Business Update and Report..
2023/7/2021:04EDGAR2Form 8-K - Current report
2023/7/2021:00GLOBEVir Biotechnology Announces Topline Data from Phase 2..
2023/7/0610:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0110:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/3006:01EDGAR2Form 144 - Report of proposed sale of securities
2023/6/2922:00GLOBEVir Biotechnology Appoints Sasha Damouni Ellis as Executive..

最近閲覧した銘柄

NASDAQ
VIR
Vir Biotechnology
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有